Klaus Fenchel

1.2k total citations
31 papers, 855 citations indexed

About

Klaus Fenchel is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Klaus Fenchel has authored 31 papers receiving a total of 855 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Immunology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Klaus Fenchel's work include Lung Cancer Treatments and Mutations (6 papers), Blood disorders and treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Klaus Fenchel is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Blood disorders and treatments (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Klaus Fenchel collaborates with scholars based in Germany, United Kingdom and Austria. Klaus Fenchel's co-authors include Wolfram C. M. Dempke, Peter Uciechowski, Lothar Bergmann, Stephen Dale, D. Hoelzer, P.S. Mitrou, Bernhard Jahn, Eckhart Weidmann, Jürgen Brieger and Paris S. Mitrou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Oncology.

In The Last Decade

Klaus Fenchel

29 papers receiving 828 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Fenchel Germany 14 340 287 258 164 154 31 855
M. Testi Italy 19 244 0.7× 174 0.6× 289 1.1× 296 1.8× 166 1.1× 62 983
Leo M. Budel Netherlands 13 332 1.0× 161 0.6× 201 0.8× 108 0.7× 70 0.5× 24 780
Mona Anand India 18 209 0.6× 175 0.6× 252 1.0× 92 0.6× 272 1.8× 43 908
Stephen J. Forman United States 19 298 0.9× 203 0.7× 222 0.9× 72 0.4× 127 0.8× 34 962
Cyrus Sayehli Germany 14 499 1.5× 245 0.9× 218 0.8× 87 0.5× 78 0.5× 37 831
Annet Simons Netherlands 17 144 0.4× 111 0.4× 239 0.9× 145 0.9× 198 1.3× 29 800
T Philip France 14 265 0.8× 165 0.6× 206 0.8× 97 0.6× 76 0.5× 46 692
Monika Csóka Hungary 15 339 1.0× 164 0.6× 266 1.0× 155 0.9× 66 0.4× 57 876
A. David B. Webster United Kingdom 18 145 0.4× 702 2.4× 242 0.9× 164 1.0× 198 1.3× 20 1.0k
Chunji Gao China 16 226 0.7× 131 0.5× 258 1.0× 99 0.6× 256 1.7× 77 897

Countries citing papers authored by Klaus Fenchel

Since Specialization
Citations

This map shows the geographic impact of Klaus Fenchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Fenchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Fenchel more than expected).

Fields of papers citing papers by Klaus Fenchel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Fenchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Fenchel. The network helps show where Klaus Fenchel may publish in the future.

Co-authorship network of co-authors of Klaus Fenchel

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Fenchel. A scholar is included among the top collaborators of Klaus Fenchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Fenchel. Klaus Fenchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dempke, Wolfram C. M. & Klaus Fenchel. (2024). Targeting C797S mutations and beyond in non-small cell lung cancer—a mini-review. Translational Cancer Research. 13(11). 6540–6549. 2 indexed citations
2.
Cinetto, Francesco, Klaus Fenchel, Riccardo Scarpa, et al.. (2023). Use of immunoglobulin replacement therapy in patients with secondary antibody deficiency in daily practice: a European expert Q&A-based review. Expert Review of Hematology. 16(4). 237–243. 1 indexed citations
3.
Dempke, Wolfram C. M. & Klaus Fenchel. (2021). Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?—a narrative review. Translational Lung Cancer Research. 10(6). 2667–2682. 11 indexed citations
4.
Frost, Nikolaj, Petros Christopoulos, Diego Kauffmann‐Guerrero, et al.. (2021). Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program. Therapeutic Advances in Medical Oncology. 13. 3863595598–3863595598. 33 indexed citations
5.
6.
7.
Dempke, Wolfram C. M., Peter Uciechowski, Klaus Fenchel, & Timothy Chevassut. (2018). Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?. Oncology. 95(5). 257–269. 55 indexed citations
8.
Dempke, Wolfram C. M., Klaus Fenchel, Peter Uciechowski, & Timothy Chevassut. (2017). Targeting Developmental Pathways: The Achilles Heel of Cancer?. Oncology. 93(4). 213–223. 19 indexed citations
9.
Wagner, Gunnar, et al.. (2011). Leukemia cutis – epidemiology, clinical presentation, and differential diagnoses. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 10(1). 27–36. 64 indexed citations
10.
Schmidt, K. L., et al.. (2004). Neutrophil CD177 (NB1 gp, HNA‐2a) expression is increased in severe bacterial infections and polycythaemia vera. British Journal of Haematology. 126(2). 252–254. 68 indexed citations
11.
Hauck, E. W., H. Schmelz, Thorsten Diemer, et al.. (2003). Epithelioid sarcoma of the penis—a rare differential diagnosis of Peyronie's disease. International Journal of Impotence Research. 15(5). 378–382. 11 indexed citations
12.
Karthaus, Meinolf, Gerlinde Egerer, Klaus Fenchel, et al.. (1999). Interventional Once-Daily Administration of Ceftriaxone in Leukemia and Lymphoma Patients with Febrile Neutropenia. PubMed. 50. 26–36. 1 indexed citations
13.
Fenchel, Klaus, et al.. (1999). Cytotoxic Drug Extravasation. PubMed. 50. 144–148. 4 indexed citations
14.
Fenchel, Klaus, et al.. (1997). Protein A-Immunoadsorption in Chemotherapy Associated Hemolytic-uremic Syndrome. Transfusion Science. 19. 5–7. 12 indexed citations
15.
Jahn, Bernhard, Lothar Bergmann, Eckhart Weidmann, et al.. (1995). Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity. Leukemia Research. 19(2). 73–82. 24 indexed citations
16.
Fenchel, Klaus, et al.. (1995). Clinical Experience with Fludarabine and its Immunosuppressive Effects in Pretreated Chronic Lymphocytic Leukemias and Low-Grade Lymphomas. Leukemia & lymphoma. 18(5-6). 485–492. 55 indexed citations
17.
Fenchel, Klaus, et al.. (1994). Fludarabine is an Effective Agent in Immunocytic Lymphoma. Oncology Research and Treatment. 17(5). 508–513. 8 indexed citations
18.
19.
Bergmann, Lothar, Klaus Fenchel, Bernhard Jahn, P.S. Mitrou, & D. Hoelzer. (1993). Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Annals of Oncology. 4(5). 371–375. 78 indexed citations
20.
Göke, Burkhard, et al.. (1988). Increased CCK-Response to Proteinase Inhibitor Feeding After Induction of Pancreatic Hypertrophy in Rats. Pancreas. 3(5). 576–579. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Testi Breakdown of academic impact, for papers by Leo M. Budel Breakdown of academic impact, for papers by Mona Anand Breakdown of academic impact, for papers by Stephen J. Forman Breakdown of academic impact, for papers by Cyrus Sayehli Breakdown of academic impact, for papers by Annet Simons Breakdown of academic impact, for papers by T Philip Breakdown of academic impact, for papers by Monika Csóka Breakdown of academic impact, for papers by A. David B. Webster Breakdown of academic impact, for papers by Chunji Gao
Rankless by CCL
2026